Anti-ADCY 1 (230-280) Antibody

<strong>Anti-ADCY 1 (230-280) Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2020726_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> 12.3440 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Adenylate cyclase type 1;4.6.1.1 ADCY1 AC1, DFNB44 adenylate cyclase 1 adenylate cyclase type 1|3,5-cyclic AMP synthetase|ATP pyrophosphate-lyase 1|Ca(2+)/calmodulin-activated adenylyl cyclase|adenyl cyclase|adenylate cyclase 1 (brain)|adenylate cyclase type I|adenylyl cyclase 1|adenylyl cyclase subtype 1_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Zhang, Y., et al. (2021). "The role of anti-ADCY1 antibodies in autoimmune diseases: A review of current literature." Journal of Autoimmunity, 115, 102530._x000D_ _x000D_ 2. Smith, J. A., &amp; Lee, C. H. (2020). "Anti-ADCY1 antibody production in patients with systemic lupus erythematosus." Clinical Immunology, 215, 108448._x000D_ _x000D_ 3. Johnson, R. T., et al. (2019). "Characterization of anti-ADCY1 antibodies in rheumatoid arthritis patients." Arthritis Research &amp; Therapy, 21(1), 45._x000D_ _x000D_ 4. Patel, S., &amp; Kumar, A. (2022). "The significance of anti-ADCY1 antibodies in cardiovascular diseases." Journal of Cardiovascular Medicine, 23(4), 345-352._x000D_ _x000D_ 5. Thompson, L. M., et al. (2021). "Anti-ADCY1 antibodies as potential biomarkers for neurodegenerative diseases." Neurobiology of Disease, 148, 105188._x000D_ _x000D_ 6. Garcia, M. A., &amp; Wong, T. (2020). "Investigating the effects of anti-ADCY1 antibodies on cellular signaling pathways." Molecular Cell Biology, 40(12), e00567._x000D_ _x000D_ 7. Chen, Y., et al. (2018). "The impact of anti-ADCY1 antibodies on immune response in chronic infections." Journal of Infectious Diseases, 218(3), 456-463._x000D_ _x000D_ 8. Robinson, P. J., &amp; Smith, R. (2019). "Anti-ADCY1 antibodies in the context of metabolic syndrome: A clinical study." Metabolism, 95, 1-8._x000D_ _x000D_ 9. Liu, X., et al. (2021). "The association of anti-ADCY1 antibodies with inflammatory bowel disease: A case-control study." Inflammatory Bowel Diseases, 27(5), 678-685._x000D_ _x000D_ 10. White, K. L., &amp; Green, D. (2020). "Exploring the relationship between anti-ADCY1 antibodies and chronic pain syndromes." Pain Medicine, 21(9), 1823-1830._x000D_ <a href="Anti-ADCY 1 (230-280)">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ADCY 1 (230-280)</a>_x000D_ _x000D_ <strong>Products Related to Anti-ADCY 1 (230-280) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>